Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

0.00%

0.8¢ anagenics limited

Maria Halasz Share Price Tracker, page-30

First 30 Last

Share
Profile

Follow
Taurean7

1,776 Posts.

3110

06/03/15

23:10

Post #: 14875481
Share

Originally posted by Ooogerbooger ↑

I asked her about a timeline for the midkine antibody program. While I did not ask her if I could release the details, I don't see any problem with posting an excerpt:
"With the funds raised we will be able to progress to a pre-IND meeting by completing (human in vitro) tissue cross reactivity and single dose toxicity studies (page 1 of our newsletter). These are significant milestones and go towards de-risking the program. As you point out toxicity is one of the areas we need to address and these will be the first ever formal toxicology studies of our antibody.

We have released the approximate timing of the pre-IND meeting as mid 2015 although it will depend on many factors, some outside of our control, like the FDA. On the other hand, the timing of the clinical trials will depend on availability of funding, manufacturing timetables, clinical facilities etc. Hence it is not possible to commit to a timeline at this stage on this front. "

Overall, the email gave the impression of competence and it was not formulaic. She scored brownie points with me for it.

I'm anticipating shrill cries of derision on this forum in response to this post. I'm not proposing to respond to them or to engage in further correspondence on HC about this or any other matters. For many months I have followed the HC forums without registering or posting. I am going to revert to that policy, because there is way too much name-calling and emoting here and the moderation is used like a blunt instrument. Cheers.

Expand

Thanks for the information Oooger. Sorry to see you go. The forum could only benefit from more of your rational commentary.

Cheers

CDY Price at posting: 2.4¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 4 more messages in this thread...

First 30 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Maria Halasz Share Price Tracker, page-30

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Featured News

Maria Halasz Share Price Tracker, page-30

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Featured News